<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04833738</url>
  </required_header>
  <id_info>
    <org_study_id>Yuzuncu Yil University</org_study_id>
    <nct_id>NCT04833738</nct_id>
  </id_info>
  <brief_title>Hyaluronic Acid, Corticosteroid and Electrotherapy in Subacromial Impingement Syndrome</brief_title>
  <official_title>Subakromiyal sıkışma Sendromunda Hyaluronik Asit, Kortikosteroid ve Elektroterapi</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Şeyhmus KAPLAN</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yuzuncu Yıl University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: Electrotherapy, corticosteroid, and hyaluronic acid have been used to treat&#xD;
      subacromial impingement syndrome. However, we need to compare treatment options to provide&#xD;
      the optimal results. This study aims to compare the effect of hyaluronic acid,&#xD;
      corticosteroid, and electrotherapy in subacromial impingement syndrome.&#xD;
&#xD;
      Design: Ninety five patients were randomised into three equal groups according to treatment&#xD;
      types. Hyaluronic acid (20 mg/2ml, three times one week apart) or corticosteroid&#xD;
      (triamcinolone acetonide, 40 mg/ml, single dose) treatments were applied as subacromial&#xD;
      injections. Electrotherapy consisted of 14 sessions TENS (20 min.), hotpack (20 min.) and&#xD;
      ultrasound (1.5watt/cm2, 1 MHz, 6 min.). Patients were evaluated before treatment, one and&#xD;
      four weeks post end of treatment. Visual Analogue Scale (VAS), range of motion (ROM), and&#xD;
      Shoulder Disability Questionnaire (SDQ) were used as outcome measures.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 11, 2013</start_date>
  <completion_date type="Actual">May 28, 2014</completion_date>
  <primary_completion_date type="Actual">December 10, 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Analogue Scale</measure>
    <time_frame>1 min.</time_frame>
    <description>Higher scores represent higher level of shoulder pain.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>range of motion</measure>
    <time_frame>5 min.</time_frame>
    <description>Higher scores represent lower level of shoulder function.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Shoulder Disability Questionnaire</measure>
    <time_frame>15 min</time_frame>
    <description>Higher scores represent higher level of shoulder pain.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Subacromial Impingement</condition>
  <condition>Pain, Shoulder</condition>
  <arm_group>
    <arm_group_label>Electrotherapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>corticosteroid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>hyaluronic acid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Hyaluronic acid</intervention_name>
    <arm_group_label>hyaluronic acid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Corticosteroids Triamcinolone Acetonide</intervention_name>
    <description>triamcinolone acetonide, 40 mg/ml, single dose</description>
    <arm_group_label>corticosteroid</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Electrotherapy</intervention_name>
    <description>electrotherapy</description>
    <arm_group_label>Electrotherapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The diagnosis of subacromial impingement syndrome&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients aged &lt;20 or &gt;50 years or who have the following medical conditions were&#xD;
             excluded: physical therapy or injection in the past 6 months, shoulder instability,&#xD;
             acute trauma, adhesive capsulitis, psychiatric illness, diabetes mellitus, malignancy.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>April 2, 2021</study_first_submitted>
  <study_first_submitted_qc>April 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 6, 2021</study_first_posted>
  <last_update_submitted>April 5, 2021</last_update_submitted>
  <last_update_submitted_qc>April 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Yuzuncu Yıl University</investigator_affiliation>
    <investigator_full_name>Şeyhmus KAPLAN</investigator_full_name>
    <investigator_title>Department of Sports Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Shoulder Impingement Syndrome</mesh_term>
    <mesh_term>Shoulder Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Triamcinolone</mesh_term>
    <mesh_term>Triamcinolone Acetonide</mesh_term>
    <mesh_term>Triamcinolone hexacetonide</mesh_term>
    <mesh_term>Hyaluronic Acid</mesh_term>
    <mesh_term>Triamcinolone diacetate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

